Christopher A Bleck - Net Worth and Insider Trading
Christopher A Bleck Net Worth
The estimated net worth of Christopher A Bleck is at least $10 dollars as of 2024-11-13. Christopher A Bleck is the Chief Commercial Officer of Millendo Therapeutics Inc and owns about 9 shares of Millendo Therapeutics Inc (MLND) stock worth over $10. Details can be seen in Christopher A Bleck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher A Bleck has not made any transactions after 2013-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher A Bleck
Christopher A Bleck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher A Bleck owns 2 companies in total, including Millendo Therapeutics Inc (MLND) , and Tempest Therapeutics Inc (TPST) .
Click here to see the complete history of Christopher A Bleck’s form 4 insider trades.
Insider Ownership Summary of Christopher A Bleck
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLND | Millendo Therapeutics Inc | 2013-09-11 | Chief Commercial Officer |
| TPST | Tempest Therapeutics Inc | 2013-09-11 | Chief Commercial Officer |
Christopher A Bleck Latest Holdings Summary
Christopher A Bleck currently owns a total of 1 stock. Christopher A Bleck owns 9 shares of Millendo Therapeutics Inc (MLND) as of September 11, 2013, with a value of $10.
Latest Holdings of Christopher A Bleck
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLND | Millendo Therapeutics Inc | 2013-09-11 | 9 | 1.06 | 10 |
Holding Weightings of Christopher A Bleck
Christopher A Bleck Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher A Bleck has made a total of 0 transactions in Millendo Therapeutics Inc (MLND) over the past 5 years. The most-recent trade in Millendo Therapeutics Inc is the acquisition of 9 shares on September 11, 2013, which cost Christopher A Bleck around $22,300.
Insider Trading History of Christopher A Bleck
- 1
Christopher A Bleck Trading Performance
GuruFocus tracks the stock performance after each of Christopher A Bleck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher A Bleck is -16.44%. GuruFocus also compares Christopher A Bleck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher A Bleck within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher A Bleck's insider trading performs compared to the benchmark.
Performance of Christopher A Bleck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.88 | | | | | |
| Relative Return to S&P 500(%) | -13.71 | | | | | |
Christopher A Bleck Ownership Network
Ownership Network List of Christopher A Bleck
Ownership Network Relation of Christopher A Bleck
Christopher A Bleck Owned Company Details
What does Millendo Therapeutics Inc do?
Who are the key executives at Millendo Therapeutics Inc?
Christopher A Bleck is the Chief Commercial Officer of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Medical Officer Christophe Arbet-engels , Chief Development Officer Ryan Zeidan , and director & President and CEO Julia C. Owens .
Millendo Therapeutics Inc (MLND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Millendo Therapeutics Inc Insider Transactions
Christopher A Bleck Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher A Bleck. Currently GuruFocus does not have mailing address information for Christopher A Bleck.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
